Defining the molecular basis of interaction between R3 receptor-type protein tyrosine phosphatases and VE-cadherin.

Receptor-type protein tyrosine phosphatases (RPTPs) of the R3 subgroup play key roles in the immune, vascular and nervous systems. They are characterised by a large ectodomain comprising multiple FNIII-like repeats, a transmembrane domain, and a single intracellular phosphatase domain. The functiona...

Full description

Bibliographic Details
Main Authors: Olga Dorofejeva, Alastair J Barr
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5604967?pdf=render
id doaj-2cf09de1eed14cd48105acd079156ac6
record_format Article
spelling doaj-2cf09de1eed14cd48105acd079156ac62020-11-24T21:36:17ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01129e018457410.1371/journal.pone.0184574Defining the molecular basis of interaction between R3 receptor-type protein tyrosine phosphatases and VE-cadherin.Olga DorofejevaAlastair J BarrReceptor-type protein tyrosine phosphatases (RPTPs) of the R3 subgroup play key roles in the immune, vascular and nervous systems. They are characterised by a large ectodomain comprising multiple FNIII-like repeats, a transmembrane domain, and a single intracellular phosphatase domain. The functional role of the extracellular region has not been clearly defined and potential roles in ligand interaction, dimerization, and regulation of cell-cell contacts have been reported. Here bimolecular fluorescence complementation (BiFC) in live cells was used to examine the molecular basis for the interaction of VE-PTP with VE-cadherin, two proteins involved in endothelial cell contact and maintenance of vascular integrity. The potential of other R3-PTPs to interact with VE-cadherin was also explored using this method. Quantitative BiFC analysis, using a VE-PTP construct expressing only the ectodomain and transmembrane domain, revealed a specific interaction with VE-cadherin, when compared with controls. Controls were sialophorin, an unrelated membrane protein with a large ectodomain, and a membrane anchored C-terminal Venus-YFP fragment, lacking both ectodomain and transmembrane domains. Truncation of the first 16 FNIII-like repeats from the ectodomain of VE-PTP indicated that removal of this region is not sufficient to disrupt the interaction with VE-cadherin, although it occurs predominantly in an intracellular location. A construct with a deletion of only the 17th domain of VE-PTP was, in contrast to previous studies, still able to interact with VE-cadherin, although this also was predominantly intracellular. Other members of the R3-PTP family (DEP-1, GLEPP1 and SAP-1) also exhibited the potential to interact with VE-cadherin. The direct interaction of DEP-1 with VE-cadherin is likely to be of physiological relevance since both proteins are expressed in endothelial cells. Together the data presented in the study suggest a role for both the ectodomain and transmembrane domain of R3-PTPs in interaction with VE-cadherin.http://europepmc.org/articles/PMC5604967?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Olga Dorofejeva
Alastair J Barr
spellingShingle Olga Dorofejeva
Alastair J Barr
Defining the molecular basis of interaction between R3 receptor-type protein tyrosine phosphatases and VE-cadherin.
PLoS ONE
author_facet Olga Dorofejeva
Alastair J Barr
author_sort Olga Dorofejeva
title Defining the molecular basis of interaction between R3 receptor-type protein tyrosine phosphatases and VE-cadherin.
title_short Defining the molecular basis of interaction between R3 receptor-type protein tyrosine phosphatases and VE-cadherin.
title_full Defining the molecular basis of interaction between R3 receptor-type protein tyrosine phosphatases and VE-cadherin.
title_fullStr Defining the molecular basis of interaction between R3 receptor-type protein tyrosine phosphatases and VE-cadherin.
title_full_unstemmed Defining the molecular basis of interaction between R3 receptor-type protein tyrosine phosphatases and VE-cadherin.
title_sort defining the molecular basis of interaction between r3 receptor-type protein tyrosine phosphatases and ve-cadherin.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2017-01-01
description Receptor-type protein tyrosine phosphatases (RPTPs) of the R3 subgroup play key roles in the immune, vascular and nervous systems. They are characterised by a large ectodomain comprising multiple FNIII-like repeats, a transmembrane domain, and a single intracellular phosphatase domain. The functional role of the extracellular region has not been clearly defined and potential roles in ligand interaction, dimerization, and regulation of cell-cell contacts have been reported. Here bimolecular fluorescence complementation (BiFC) in live cells was used to examine the molecular basis for the interaction of VE-PTP with VE-cadherin, two proteins involved in endothelial cell contact and maintenance of vascular integrity. The potential of other R3-PTPs to interact with VE-cadherin was also explored using this method. Quantitative BiFC analysis, using a VE-PTP construct expressing only the ectodomain and transmembrane domain, revealed a specific interaction with VE-cadherin, when compared with controls. Controls were sialophorin, an unrelated membrane protein with a large ectodomain, and a membrane anchored C-terminal Venus-YFP fragment, lacking both ectodomain and transmembrane domains. Truncation of the first 16 FNIII-like repeats from the ectodomain of VE-PTP indicated that removal of this region is not sufficient to disrupt the interaction with VE-cadherin, although it occurs predominantly in an intracellular location. A construct with a deletion of only the 17th domain of VE-PTP was, in contrast to previous studies, still able to interact with VE-cadherin, although this also was predominantly intracellular. Other members of the R3-PTP family (DEP-1, GLEPP1 and SAP-1) also exhibited the potential to interact with VE-cadherin. The direct interaction of DEP-1 with VE-cadherin is likely to be of physiological relevance since both proteins are expressed in endothelial cells. Together the data presented in the study suggest a role for both the ectodomain and transmembrane domain of R3-PTPs in interaction with VE-cadherin.
url http://europepmc.org/articles/PMC5604967?pdf=render
work_keys_str_mv AT olgadorofejeva definingthemolecularbasisofinteractionbetweenr3receptortypeproteintyrosinephosphatasesandvecadherin
AT alastairjbarr definingthemolecularbasisofinteractionbetweenr3receptortypeproteintyrosinephosphatasesandvecadherin
_version_ 1725941952521699328